Covered recipient · General Payments record
ANDREA G ALEXANDER
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,171.08
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $726.58 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $297.09 | 15 |
| UCB, Inc. | $73.14 | 4 |
| Lilly USA, LLC | $56.41 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $54.91 | 3 |
| GENZYME CORPORATION | $54.17 | 2 |
| Amgen Inc. | $50.27 | 2 |
| Arcutis Biotherapeutics, Inc. | $23.45 | 1 |
| Janssen Biotech, Inc. | $21.56 | 1 |
| PFIZER INC. | $21.22 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.15 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.07 | 1 |
| LEO Pharma Inc. | $19.11 | 1 |
| Regeneron Healthcare Solutions, Inc. | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.38 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200263 | CMS |
| ABBVIE INC. | $20.74 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200265 | CMS |
| ABBVIE INC. | $29.36 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200267 | CMS |
| ABBVIE INC. | $19.68 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200269 | CMS |
| ABBVIE INC. | $17.56 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200271 | CMS |
| ABBVIE INC. | $21.84 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200273 | CMS |
| ABBVIE INC. | $28.64 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200275 | CMS |
| ABBVIE INC. | $15.38 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200277 | CMS |
| ABBVIE INC. | $20.44 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200279 | CMS |
| ABBVIE INC. | $17.60 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200281 | CMS |
| ABBVIE INC. | $20.99 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200283 | CMS |
| ABBVIE INC. | $4.47 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200285 | CMS |
| ABBVIE INC. | $13.36 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200287 | CMS |
| ABBVIE INC. | $18.68 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200289 | CMS |
| ABBVIE INC. | $26.97 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103200291 | CMS |
| Amgen Inc. | $18.26 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117187147 | CMS |
| Amgen Inc. | $32.01 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117187149 | CMS |
| Arcutis Biotherapeutics, Inc. | $23.45 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121034640 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.15 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101702740 | CMS |
| GENZYME CORPORATION | $29.17 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139787855 | CMS |
| GENZYME CORPORATION | $25.00 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139787861 | CMS |
| Janssen Biotech, Inc. | $21.56 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078536385 | CMS |
| LEO Pharma Inc. | $19.11 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152618413 | CMS |
| Lilly USA, LLC | $23.42 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136032582 | CMS |
| Lilly USA, LLC | $32.99 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136035586 | CMS |
| Novartis Pharmaceuticals Corporation | $20.07 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086676741 | CMS |
| PFIZER INC. | $21.22 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131478617 | CMS |
| Regeneron Healthcare Solutions, Inc. | $14.03 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113996982 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.33 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152124699 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.60 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152124695 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.98 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152124697 | CMS |
| UCB, Inc. | $17.28 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143130645 | CMS |
| UCB, Inc. | $17.88 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143130650 | CMS |
| UCB, Inc. | $17.99 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143130654 | CMS |
| UCB, Inc. | $19.99 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143130658 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.